Navigation Links
Drug interactions with warfarin
Date:8/13/2007

Anticoagulants (e.g., warfarin) and antiplatelet drugs (e.g., acetylsalicylic acid) are key therapeutic agents in the treatment of cardiovascular diseases. In this study, Joseph Delaney MSc, Dr. James Brophy and colleagues looked for drugdrug interactions in 4,028 cases with a diagnosis of gastrointestinal bleeding and 40,171 matched controls in the United Kingdom. They documented a 46-fold increase in the rate of gastrointestinal bleeding associated with the combined use of the anticoagulant warfarin and antiplatelet agents. This real-world study of prescription data from general practices observed much higher rates of bleeding than those derived from a meta-analysis of randomized clinical trials. The authors write that physicians should be aware of these risks to better assess their patients therapeutic riskbenefit profiles.

In a related commentary, David Juurlink PhD explains the main drug interactions with the anticoagulant warfarin.


'/>"/>
Contact: Dr. James Brophy
james.brophy@mcgill.ca
514-934-1934 x36771
Canadian Medical Association Journal
Source:Eurekalert

Page: 1

Related medicine news :

1. Rush Study Shows That Interactions with Friends and Family Prevents Damaging Effects of Alzheimers disease
2. Techniques for analyzing protein interactions aid in detecting the molecular basis of diseases
3. Cancer Patients are at High Risk for Potential Drug Interactions
4. Protein Interactions Targets for Huntington Disease Therapy
5. Studies Identify Interactions Between Heart Disease, Kidney Disease
6. Studies Identify Interactions Between Heart Disease, Kidney Disease
7. Interactions Between Food and Drugs Could Lower Drug Costs
8. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
9. Comparison between warfarin and aspirin
10. An Alternative to Warfarin
11. New Blood Thinner Pill - First Potential Alternative to Warfarin in 50 years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 2016 BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s ... achieved through user experience. , BOC Global Events & Training Group is a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, LA.c., a certified ... Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility ... patients realize their family building goals. Acupuncture helps fertility patients by ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a brief ... the presidency and to America. “Tomorrow Trump Goes To Washington” is the creation of ... can for this country. , Nancy attributes her patriotic nature to her WWII veteran ...
(Date:12/7/2016)... ... ... “Fred Rides a Train” allows readers to tag along on a special ... Train” is the creation of published author, Janet Morrison, who has been writing mostly ... "Fred, the Dog" series is her first attempt at writing for children. Janet, Fred, ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Inc. (NASDAQ: IONS ), the leader in antisense therapeutics, ... BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December ... A live webcast of the presentation will be available on the ... be available within 48 hours and will be archived for a ... , , ...
(Date:12/7/2016)... PHILADELPHIA , Dec. 7, 2016  Lannett Company, Inc. (NYSE: ... at the BMO Capital Markets 2016 Prescription for Success Healthcare Conference ... Barclay hotel in New York City . ... investors participating at the Guggenheim Securities 4 th Annual Boston ... Boston hotel. ...
(Date:12/6/2016)... 2016  Alopexx Oncology, LLC announced data from a ... protein (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal ... B cells as Rituxan and maintains the activities of ... involved in tumor targeting, engagement of the immune system, ... of the study (abstract #95954) were presented at the ...
Breaking Medicine Technology: